These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Presenilin 1 is involved in the maturation of beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1). Kuzuya A; Uemura K; Kitagawa N; Aoyagi N; Kihara T; Ninomiya H; Ishiura S; Takahashi R; Shimohama S J Neurosci Res; 2007 Jan; 85(1):153-65. PubMed ID: 17075903 [TBL] [Abstract][Full Text] [Related]
3. Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis. Bjelik A; Bereczki E; Gonda S; Juhász A; Rimanóczy A; Zana M; Csont T; Pákáski M; Boda K; Ferdinandy P; Dux L; Janka Z; Sántha M; Kálmán J Neurochem Int; 2006 Sep; 49(4):393-400. PubMed ID: 16546298 [TBL] [Abstract][Full Text] [Related]
4. Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent. Hartlage-Rübsamen M; Zeitschel U; Apelt J; Gärtner U; Franke H; Stahl T; Günther A; Schliebs R; Penkowa M; Bigl V; Rossner S Glia; 2003 Jan; 41(2):169-79. PubMed ID: 12509807 [TBL] [Abstract][Full Text] [Related]
5. Beta-secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signaling. Züchner T; Perez-Polo JR; Schliebs R J Neurosci Res; 2004 Jul; 77(2):250-7. PubMed ID: 15211591 [TBL] [Abstract][Full Text] [Related]
6. BACE2 plays a role in the insulin receptor trafficking in pancreatic ß-cells. Casas S; Casini P; Piquer S; Altirriba J; Soty M; Cadavez L; Gomis R; Novials A Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E1087-95. PubMed ID: 20943756 [TBL] [Abstract][Full Text] [Related]
7. The Swedish APP mutation alters the effect of genetically reduced BACE1 expression on the APP processing. Rabe S; Reichwald J; Ammaturo D; de Strooper B; Saftig P; Neumann U; Staufenbiel M J Neurochem; 2011 Oct; 119(1):231-9. PubMed ID: 21812781 [TBL] [Abstract][Full Text] [Related]
8. The transcription factor Yin Yang 1 is an activator of BACE1 expression. Nowak K; Lange-Dohna C; Zeitschel U; Günther A; Lüscher B; Robitzki A; Perez-Polo R; Rossner S J Neurochem; 2006 Mar; 96(6):1696-707. PubMed ID: 16539685 [TBL] [Abstract][Full Text] [Related]
9. BACE1 gene expression and protein degradation. Zhou W; Qing H; Tong Y; Song W Ann N Y Acad Sci; 2004 Dec; 1035():49-67. PubMed ID: 15681800 [TBL] [Abstract][Full Text] [Related]
12. Transcriptional and translational regulation of BACE1 expression--implications for Alzheimer's disease. Rossner S; Sastre M; Bourne K; Lichtenthaler SF Prog Neurobiol; 2006 Jun; 79(2):95-111. PubMed ID: 16904810 [TBL] [Abstract][Full Text] [Related]
13. Protein expression of BACE1, BACE2 and APP in Down syndrome brains. Cheon MS; Dierssen M; Kim SH; Lubec G Amino Acids; 2008 Aug; 35(2):339-43. PubMed ID: 18163181 [TBL] [Abstract][Full Text] [Related]
14. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1. Sankaranarayanan S; Price EA; Wu G; Crouthamel MC; Shi XP; Tugusheva K; Tyler KX; Kahana J; Ellis J; Jin L; Steele T; Stachel S; Coburn C; Simon AJ J Pharmacol Exp Ther; 2008 Mar; 324(3):957-69. PubMed ID: 18156464 [TBL] [Abstract][Full Text] [Related]
15. Beta-amyloid secretases and beta-amloid degrading enzyme expression in lens. Li G; Percontino L; Sun Q; Qazi AS; Frederikse PH Mol Vis; 2003 May; 9():179-83. PubMed ID: 12740567 [TBL] [Abstract][Full Text] [Related]
16. Effects of galantamine on β-amyloid release and beta-site cleaving enzyme 1 expression in differentiated human neuroblastoma SH-SY5Y cells. Li Q; Wu D; Zhang L; Zhang Y Exp Gerontol; 2010 Nov; 45(11):842-7. PubMed ID: 20600777 [TBL] [Abstract][Full Text] [Related]